Atlas Trials

Sorafenib With BIIB022 in Hepatocellular Carcinoma (HCC)

Clinical trial NCT00956436 · COMPLETED

Trial details

NCT number
NCT00956436
Sponsor
Biogen
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Hepatocellular Carcinoma
Start date
2009-08-01
Primary completion
2011-04-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.